The largest database of trusted experimental protocols

7 protocols using anti c myc

1

Western Blotting of Mammosphere Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting procedures were carried out as previously described (15 ). Briefly, cells were collected in RIPA lysis buffer (150mM NaCl, 1% NP40, 0.5% DOC, 50mM Tris-HCl at pH 8, 0.1% SDS, 10% glycerol, 5mM EDTA, 20mM NaF and 1mM Na3VO4, 1 μg/ml each of pepstatin, leupeptin, and aprotinin, 200 μg/ml phenyl-methylsulfonyl-fluoride). Lysates were cleared by centrifugation at 14,000 x g for 20 minutes at 4 °C and analyzed by SDS-PAGE and autoradiography. Lysates from mammospheres were collected 7 days after culture in mammosphere media. Corresponding adherent controls were put on mammosphere media 24 hrs after seeding and collected the next day. Antibodies were purchased from the following companies; Anti-OGT (Santa Cruz, Cell-Signaling), Anti-O-GlcNAc (Santa Cruz, Sigma), Anti-c-Myc (Novus), Anti-Actin (Santa Cruz), Anti-CD44, Anti-Fibronectin, Anti-Vimentin, Anti-NANOG (Cell-Signaling), Anti-K8/18 (Thermo-Fisher), Anti-K14 (Thermo-Fisher), Anti-GAPDH (Genscript), Anti-KLF8 (Sigma). Densitometry was performed using Image J Software (National Institutes of Health, Bethesda, MA).
+ Open protocol
+ Expand
2

Protein Expression Analysis in Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected and washed three-times with ice-cold PBS to remove residue media. Then cell pellets were resuspended in cold RIPA lysis buffer (150mM NaCl, 1% NP40, 0.5% DOC, 50mM Tris-HCl at pH 8, 0.1% SDS, 10% glycerol, 5mM EDTA, 20mM NaF and 1mM Na3VO4), supplemented with protease inhibitors. Cell debris was removed by centrifugation at 15000 rpm for 20 minutes at 4°C using benchtop centrifuge. Protein concentration was determined flowing Bradford assay. 50 µg of protein from each sample was separated by SDS-PAGE and transferred to PVDF membrane. Target proteins were detected using indicated specific antibodies: Anti-OGT (Cell-Signaling, cat #20438), Anti-O-GlcNAc (Sigma, cat #MABS1254), Anti-c-MYC (Novus, cat #NB600-335), Anti-Actin (Santa Cruz, cat #sc-47778), Anti-NANOG (Cell-Signaling, cat #3580), Anti-SOX2 (Cell-Signaling, cat #3579), Anti-OCT4 (Cell-Signaling, cat #2750), Anti-KLF8 (Sigma, cat #AV32859).
+ Open protocol
+ Expand
3

Immunostaining for HIF-1α, c-Myc, YY1, MDR1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunostaining was performed as previously describe [28 (link)]. Anti-HIF-1α, anti-c-Myc, anti-YY1 or anti-MDR1 (Novus Biological, Litletown, CO, USA).
+ Open protocol
+ Expand
4

Regulation of SREBP1 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MG132, Nile Red, Methyl-pyruvate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Compound C and Dorsomorphin (2HCL) from Selleck-Chemicals (Houston, TX, USA). Ac-5sGlcNAc was provided by D. Vocadlo (Simon Fraser University). Antibodies used were Anti-OGT, Anti-O-GlcNAc, Anti-FLAG from Sigma-Aldrich; Anti-pSREBP1-(S372), Anti-pAMPK-(T172), Anti-pRaptor-(S792), Anti-pS6 Ribosomal Protein-(S240/244), Anti-p4EBP1-(T70), Anti-AMPK, Anti-Raptor, Anti-S6 Ribosomal Protein, Anti-4EBP1, Anti-FAS, Anti-ACC, Anti-Ubiquitin, Anti-Cleaved Caspase 3, Anti-Cleaved PARP from Cell Signaling (Danvers, MA, USA); Anti-Actin, Anti-Bcl2 from Santa Cruz Biotechnology; Anti-SREBP1, Anti-HIF1α, Anti-c-MYC from Novus Biologicals; Anti-SREBP1, Anti-ACLY, Anti-Glut1 from Abcam; Anti-FBW7 from Bethyl Labs. pLKO.FLAG-SREBP1 (Addgene-32017 from D. Sabatini).
+ Open protocol
+ Expand
5

Regulation of SREBP1 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MG132, Nile Red, Methyl-pyruvate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Compound C and Dorsomorphin (2HCL) from Selleck-Chemicals (Houston, TX, USA). Ac-5sGlcNAc was provided by D. Vocadlo (Simon Fraser University). Antibodies used were Anti-OGT, Anti-O-GlcNAc, Anti-FLAG from Sigma-Aldrich; Anti-pSREBP1-(S372), Anti-pAMPK-(T172), Anti-pRaptor-(S792), Anti-pS6 Ribosomal Protein-(S240/244), Anti-p4EBP1-(T70), Anti-AMPK, Anti-Raptor, Anti-S6 Ribosomal Protein, Anti-4EBP1, Anti-FAS, Anti-ACC, Anti-Ubiquitin, Anti-Cleaved Caspase 3, Anti-Cleaved PARP from Cell Signaling (Danvers, MA, USA); Anti-Actin, Anti-Bcl2 from Santa Cruz Biotechnology; Anti-SREBP1, Anti-HIF1α, Anti-c-MYC from Novus Biologicals; Anti-SREBP1, Anti-ACLY, Anti-Glut1 from Abcam; Anti-FBW7 from Bethyl Labs. pLKO.FLAG-SREBP1 (Addgene-32017 from D. Sabatini).
+ Open protocol
+ Expand
6

Western Blot Analysis of Protein Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted with lysis buffer (Tri-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% NaDOC, 0.1% SDS, 1 mM Na3VO4, 1 mM phenylmethylsulphonyl fluoride, 1 μg ml−1 pepstatin, 1 μg ml−1 aprotinine and 10 μg ml−1 leupeptine) for 20 min on ice, and protein amounts were quantified using Micro BCA Protein Assay Reagent (23235; Pierce Chemical Co.). Whole-cell lysates (40 μg per lane) were resolved on SDS–polyacrylamide gels, electrotransferred onto polyvinylidene difluoride membranes and examined by immunoblot analysis. The primary antibodies used were anti-PAX5 (610862; BD PharMingen), anti-BCL6 (#4242; Cell Signaling), anti-c-MYC (NB600-302C; Novus Biologicals), anti-IRF4 (sc-6059; Santa Cruz), anti-BLIMP1 (NB600-235; Novus Biologicals), anti-XBP1 (sc-7160; Santa Cruz), anti-HO-1 (NBP1-97507; Novus Biologicals), anti-AID (provided by Dr Alt) and anti-GAPDH (#2118; Cell Signaling). Full-sized scans of all western blots shown in Figs 3 and 6 and Supplementary Figs 11 and 12 are provided in Supplementary Fig. 14. Quantification of intensity was performed using an Image J (http://imagej.nih.gov/ij/).
+ Open protocol
+ Expand
7

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with RIPA buffer supplemented with protease and phosphatase inhibitor cocktail (Beyotime, China) to extract total proteins. After quantification, 25 μg of protein was loaded and separated with 4–12% Bis-Tris SurePAGE gels (GenScript, China) and then transferred onto PVDF membranes (Merck Millipore, Germany). After blocking with 5% BSA for 1.5 h, the membranes were incubated overnight at 4°C with anti-Sox9 (1:1000, Abcam, UK), anti-Sox2 (1:1000, Proteintech, USA), anti-Klf4 (1:1000, SAB, USA), anti-cMyc (1:1000, Novus, USA), anti-TLR4 (1:1000, Proteintech, USA), anti-YAP1 (1:1000, CST, USA), anti-CTGF (1:1000, Abcam, UK), and anti-β-actin (1:4000, Bioworld, USA) antibodies. After incubation with peroxidase-conjugated secondary antibodies (1:5000, Bioworld, USA) for 1.5 h at room temperature, the membranes were visualized using enhanced chemiluminescence detection reagents (GE Healthcare, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!